Spectrum Library

Current and emerging therapeutics for neuromyelitis optica spectrum disorder: Relevance to the COVID-19 pandemic

Publication Date June 2020

Seasonal distribution of attacks in aquaporin-4 antibody disease and myelin- oligodendrocyte antibody disease

Publication Date May 2020

Treating multiple sclerosis and neuromyelitis optica spectrum disorder during the COVID-19 pandemic.

Publication Date April 2020

Immunosuppression during the COVID-19 pandemic in neuromyelitis optica spectrum disorders patients: A new challenge

Publication Date April 2020

Neuromyelitis optica spectrum disorder Patient experience and quality of life

Publication Date July 2019

Optic neuritis at disease onset predicts poor visual outcome in neuromyelitis optica spectrum disorders

Publication Date March 2020

Neuromyelitis optica spectrum disorders in Arabian Gulf (NMOAG); establishment and initial characterization of a patient registry

Publication Date October 2019

The history of neuromyelitis optica. Part 2: ‘Spinal amaurosis’, or how it all began.

Publication Date December 2019

Late-onset neuromyelitis optica spectrum disorder: The importance of autoantibody serostatus.

Publication Date August 2019

Intradermal vaccination prevents anti-MOG autoimmune encephalomyelitis in macaques

Publication Date September 2019

Early B cell tolerance defects in NMO favour anti-AQP4 autoantibody production

Publication Date June 2019

Immune tolerance in multiple sclerosis and neuromyelitis optica with peptide-loaded tolerogenic dendritic cells in a phase 1b trial.

Publication Date April 2019

1
2
3
…
77
Next